Karpus Management, Inc. - Jun 30, 2025 SCHEDULE 13G/A Report for Drugs Made In America Acquisition Corp. Common (DMAA)

Filing Manager: Karpus Management, Inc.
Reporting Manager: KARPUS MANAGEMENT, INC.
Security: Drugs Made In America Acquisition Corp. Common
Symbol: DMAA
Shares outstanding: 33.5M shares
Disclosed Ownership: 2.74M shares
Ownership: 8.19%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 04:05 PM
Date of event: Jun 30, 2025
Previous filing: May 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
KARPUS MANAGEMENT, INC.	8.19%	2.74M	2.74M	0	/s/ Jodi L. Hedberg	Jodi L. Hedberg / Chief Compliance Officer